Origins, Treatments, and Family Perspectives – Saturday, May 7, 2005

Borderline Personality Disorder:
Origins, Treatments, and Family Perspectives

Saturday, May 7, 2005
Mary S. Harkness Auditorium, New Haven, CT

Sponsored by:

 The National Education Alliance for Borderline Personality Disorder (NEABPD) in
partnership with the National Alliance for Research on Schizophrenia and Depression (NARSAD)

 In cooperation with:

Yale-New Haven Psychiatric Hospital
Department of Psychiatry, Yale University School of Medicine
The National Alliance for the Mentally Ill-Connecticut

Conference Objectives

At the conclusion of the conference, attendees will be better able to identify, specify, and describe:1. The symptomatology of BPD
2. The current understanding of emotion dysregulation
3. The complexities of the diagnostic issues surrounding BPD
4. Issues of concern to consumers and family members
5. Research design elements and outcomes of a family program
6. The problems and options of medication programs for people with BPD
7. Three psychosocial treatment modalities

Course Description

The Conference is for physicians, psychiatrists, psychologists, social workers, family therapists, counselors, nurses, emergency room personnel, law enforcement personnel and agencies, family members, consumers, and educators.
Continuing Education credits for social workers and Certificates of Attendance are also available upon request.

Statement of Need

Borderline Personality Disorder (BPD) is a severe and generally chronic disorder and people who suffer from it are underserved. Friends and families are often bewildered and do not know how to help. Treatment programs for those with BPD need to be more readily available. Families need access to programs such as those already developed for several other mental illnesses. BPD presents patients, their families and researchers with multiple challenges. These complex challenges will be addressed in order to inform mental health professionals, families, and consumers of the most current diagnostic and treatment options available, and other issues of current interest to those affected by the disorder.

Conference Program

Moderator for the day: Seth R. Axelrod, PhD


Perry D. Hoffman, PhD
The Mount Sinai School of Medicine
President, NEABPDSeth R. Axelrod, PhD
Assistant Professor of Psychiatry
Intensive Outpatient Program DBT/DBT-S Team Leader
Yale-New Haven Psychiatric Hospital
Yale University School of Medicine

Opening Remarks

Benjamin S. Bunney, MD
Charles B.G. Murphy Professor and Chairman of Psychiatry
Professor of Pharmacology
Yale University School of Medicine

Borderline Personality Disorder: What Is It?

Robert Stern, MD, PhD
Associate Clinical Professor of Psychiatry
Yale University School of Medicine

Biopsychology of Emotion Dysregulation

Rajita Sinha, PhD
Associate Professor of Psychiatry
Director, Research Program on Stress, Addiction and Psychopathology
Director, Addiction Services
Connecticut Mental Health Center
Yale University School of Medicine

Disclosing the BPD Diagnosis: Practice and Recommendations

Richard G. Hersh, MD
Assistant Clinical Professor of Psychiatry
Columbia University College of Physicians and Surgeons
Assistant Director of the Intensive Outpatient Program
Columbia Presbyterian Medical Center

Family and Consumer Perspectives Panel, and Family Research

Dixianne Penney, Dr.PH
Executive Vice-President, NEABPD
Administrative Director
Center for the Study of Issues in Public Health
Nathan Kline Institute for Psychiatric ResearchPerry D. Hoffman, PhDEllie Buteau, PhD

Psychopharmacology of BPD: Benefits and Limitations

Kenneth R. Silk, MD
Professor and Associate Chair
Clinical and Administrative Affairs
Department of Psychiatry
University of Michigan Health System

Transference-Focused Psychotherapy

Frank E.Yeomans, MD, PhD
Director of Training
Personality Disorders Institute
Clinical Associate Professor of Psychiatry
Weill School of Medicine at Cornell University

Dialectical Behavior Therapy

George H. Davis, PhD
Clinical Director
Center for Dialectical and Cognitive Behavioral Therapies
Assistant Clinical Professor of Psychiatry
Yale University School of Medicine

Schema-Focused Therapy

Samuel A. Ball, PhD
Associate Professor of Psychiatry
Director of Training, NIDA Clinical Trials Network (New England Node)
Director of Residential Services, APT Foundation
Yale University School of Medicine
Veterans Administration Connecticut Healthcare

Treatment Panel: Question and Answer Time